Antiviral therapy favors a lower risk of liver cirrhosis in HBeAg-negative chronic hepatitis B

Antiviral therapy favors a lower risk of liver cirrhosis in HBeAg-negative chronic hepatitis B with normal alanine transaminase and HBV DNA positivity
Source: Read Full Article